bpc 157 knee pain human study BPC-157 For Pain: Early Reported Outcomes Regeneration or Risk? A Narrative
Description
2017 doi: 10.2174/1381612823666170220163219
Phase 3 trials in obesity, obesity with knee osteoarthritis, and type 2 diabetes have reported
What it does is keep the energy supply running in the cells doing the repair work
Sermorelin Sermorelin binds to the same GHRH receptors but does so more subtly, emulating the bodys natural hormonal rhythms
Q: If BPC-157 is genuinely promising, why hasn't a proper trial been done
